These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 36691218)

  • 1. An evaluation of the national testing response during the COVID-19 pandemic in England: a multistage mixed-methods study protocol.
    Naidoo R; Lambert B; Voysey M; Shretta R; Keene CM; Wanat M; Andersen-Waine B; Dahal P; Stepniewska K; Hounsell R; Molyneux S; Pinto-Duschinsky S; Rowe E; Yenidogan G; Fowler T; White L; Consortium EHA
    BMJ Open; 2024 Jun; 14(6):e077271. PubMed ID: 38885988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Informing evidence-based policy during the COVID-19 pandemic and recovery period: learning from a national evidence centre.
    Cooper A; Lewis R; Gal M; Joseph-Williams N; Greenwell J; Watkins A; Strong A; Williams D; Doe E; Law RJ; Edwards A
    Glob Health Res Policy; 2024 May; 9(1):18. PubMed ID: 38822437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in wales? Results of EVITE immunity, a linked data retrospective study" [Public Health 218 (2023) 12-20].
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Dale J; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 Sep; 222():229. PubMed ID: 37463828
    [No Abstract]   [Full Text] [Related]  

  • 4. COVID-19 and shielding: experiences of UK patients with lupus and related diseases.
    Sloan M; Gordon C; Lever E; Harwood R; Bosley MA; Pilling M; Brimicombe J; Naughton F; Blane M; Walia C; D'Cruz D
    Rheumatol Adv Pract; 2021; 5(1):rkab003. PubMed ID: 33728396
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 shielding on the wellbeing, mental health and treatment adherence of adults with cystic fibrosis.
    Westcott KA; Wilkins F; Chancellor A; Anderson A; Doe S; Echevarria C; Bourke SJ
    Future Healthc J; 2021 Mar; 8(1):e47-e49. PubMed ID: 33791475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infrastructure and operating processes of PIONEER, the HDR-UK Data Hub in Acute Care and the workings of the Data Trust Committee: a protocol paper.
    Gallier S; Price G; Pandya H; McCarmack G; James C; Ruane B; Forty L; Crosby BL; Atkin C; Evans R; Dunn KW; Marston E; Crawford C; Levermore M; Modhwadia S; Attwood J; Perks S; Doal R; Gkoutos G; Dormer R; Rosser A; Fanning H; Sapey E
    BMJ Health Care Inform; 2021 Apr; 28(1):. PubMed ID: 33849921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The National Health Service (NHS) response to the COVID-19 pandemic: a colorectal surgeons experience in the UK.
    Yano H
    Glob Health Med; 2020 Apr; 2(2):138-139. PubMed ID: 33330794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Did the UK's public health shielding policy protect the clinically extremely vulnerable during the COVID-19 pandemic in Wales? Results of EVITE Immunity, a linked data retrospective study.
    Snooks H; Watkins A; Lyons J; Akbari A; Bailey R; Bethell L; Carson-Stevens A; Edwards A; Emery H; Evans BA; Jolles S; John A; Kingston M; Porter A; Sewell B; Williams V; Lyons RA
    Public Health; 2023 May; 218():12-20. PubMed ID: 36933354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Shielding, hospital admission and mortality among 1216 people with total laryngectomy in the UK during the COVID-19 pandemic: A cross-sectional survey from the first national lockdown.
    Govender R; Behenna K; Brady G; Coffey M; Babb M; Patterson JM
    Int J Lang Commun Disord; 2021 Sep; 56(5):1064-1073. PubMed ID: 34351676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying models of care to improve outcomes for older people with urgent care needs: a mixed methods approach to develop a system dynamics model.
    Conroy S; Brailsford S; Burton C; England T; Lalseta J; Martin G; Mason S; Maynou-Pujolras L; Phelps K; Preston L; Regen E; Riley P; Street A; van Oppen J
    Health Soc Care Deliv Res; 2023 Sep; 11(14):1-183. PubMed ID: 37830206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the shielding initiative in Wales (EVITE Immunity): protocol for a quasiexperimental study.
    Evans BA; Akbari A; Bailey R; Bethell L; Bufton S; Carson-Stevens A; Dixon L; Edwards A; John A; Jolles S; Kingston MR; Lyons J; Lyons R; Porter A; Sewell B; Thornton CA; Watkins A; Whiffen T; Snooks H
    BMJ Open; 2022 Sep; 12(9):e059813. PubMed ID: 36691218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of implementing the COVID-19 shielding policy in Wales.
    Sewell B; Farr A; Akbari A; Carson-Stevens A; Dale J; Edwards A; Evans BA; John A; Torabi F; Jolles S; Kingston M; Lyons J; Lyons RA; Porter A; Watkins A; Williams V; Snooks H
    BMC Public Health; 2023 Nov; 23(1):2342. PubMed ID: 38008730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale for the shielding policy for clinically vulnerable people in the UK during the COVID-19 pandemic: a qualitative study.
    Porter A; Akbari A; Carson-Stevens A; Dale J; Dixon L; Edwards A; Evans B; Griffiths L; John A; Jolles S; Kingston MR; Lyons R; Morgan J; Sewell B; Whiffen A; Williams VA; Snooks H
    BMJ Open; 2023 Aug; 13(8):e073464. PubMed ID: 37541747
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.